May 20, 2011 — For endovascular treatment of intracranial aneurysms, hydrogel-coated coils are safe, with no evidence of worse clinical outcomes compared with bare platinum coils, and are associated ...
MIAMI & ALISO VIEJO, Calif.--(BUSINESS WIRE)-- MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation ...
Please provide your email address to receive an email when new articles are posted on . Patients with intracranial aneurysms who underwent embolization with second-generation hydrogel-coated coils ...
HOUSTON -- Treating medium-sized intracranial aneurysms with second-generation hydrogel coils diminished adverse outcomes compared with standard platinum coils, researchers reported here. Physicians ...
ALISO VIEJO, Calif., April 18, 2019 /PRNewswire/ -- MicroVention, Inc., a U.S.-based subsidiary of Terumo Corporation and a global neurovascular company, announced today the publication of the WEB-IT ...
DUBLIN, Oct. 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/j87v3m/global) has announced the addition of the "Global ...
SAN DIEGO — Final results of the randomized New Generation Hydrogel Endovascular Aneurysm Treatment (HEAT) trial show the second-generation hydrogel coil was superior to the bare platinum coil in ...
The Global Neuroendovascular Coil Market is expected to grow at 5.2% CAGR from 2025 to 2032. The Latest detailed study on the global Neuroendovascular Coil Market 2025-2032, Outlook is performed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results